| Trial name or title | A randomised controlled trial to compare the efficacy and safety of 1) macular laser vs 2) repeated intravitreal bevacizumab vs 3) combined repeated intravitreal bevacizumab with macular laser for diabetic macular edema |
| Methods | Parallel group RCT |
| Participants | People with type 2 diabetes and DMO |
| Interventions | Group 1 (Control): macular laser photocoagulation performed every 4 months unless the deferral criteria are met. Group 2: intravitreal bevacizumab injections (1.25 mg each) given at 0, 1, 2 months and repeated en bloc every 4 months unless the deferral criteria are met. Group 3: Intravitreal bevacizumab injections (1.25 mg each) given at 0, 1, 2 months, followed by macular laser photocoagulation at month 3; and repeated en bloc every 4 months unless the deferral criteria are met |
| Outcomes | BCVA at 2 years |
| Starting date | Unknown; trial registered 13 August 2013 |
| Contact information | Joyce Kung (joycekung@cuhk.edu.hk); Carmen Chan (kmcc2001@hotmail.com) |
| Notes | Status checked on Chictr.Org.Cn on 1 December 2016. Author contacted |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.